# Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/par-22-202-grand-opportunity-in-medications-development-for-substance/  
Official notice: https://www.grants.gov/search-results-detail/343339

> National Institutes of Health offered grants of up to $5.0 million to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on January 3, 2025.

| Field | Value |
|---|---|
| Opportunity number | PAR-22-202 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | January 3, 2025 |
| Award ceiling | $5.0 million |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.279 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

## What the grant funds

The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of medication for the treatment of Substance Use Disorders (SUDs) by encouraging research applications to support a diverse array of preclinical and/or clinical research projects. The goal is to fund medication studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval. It is expected that these U01s will be short-term (funded for up to 3 years) and large (up to $5 million per year) cooperative agreements with close monitoring and significant scientific involvement of NIDA staff. This funding opportunity will enable critical medications development studies that would not be feasible using the traditional R01 activity code.

## Questions people ask

### Is PAR-22-202 still open?

No. It closed on January 3, 2025.

### Who can apply for Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)?

Closed January 3, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $5.0 million each.

### Who has been funded under PAR-22-202?

NIH RePORTER lists 9 projects funded under PAR-22-202 in fiscal 2023 to 2026, at 9 institutions. The most were at Johns Hopkins University, University of Southern California, Ensysce Biosciences, Inc.

### Who has won Drug Use and Addiction Research Programs grants before?

The largest recipients over five fiscal years were Yale Univ, The Johns Hopkins University, University of California, San Diego. The program made 5,071 awards worth $7.3 billion in that time.